Rodney Barnett White
Examiner (ID: 4089, Phone: (571)272-6863 , Office: P/3636 )
Most Active Art Unit | 3636 |
Art Unit(s) | 3636, 3507, 3624 |
Total Applications | 3742 |
Issued Applications | 3058 |
Pending Applications | 192 |
Abandoned Applications | 490 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13339787
[patent_doc_number] => 20180221433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => ANGIOTENSINS IN MUSCULAR DYSTROPHY
[patent_app_type] => utility
[patent_app_number] => 15/695731
[patent_app_country] => US
[patent_app_date] => 2017-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15695731
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/695731 | ANGIOTENSINS IN MUSCULAR DYSTROPHY | Sep 4, 2017 | Abandoned |
Array
(
[id] => 13714387
[patent_doc_number] => 20170368148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => USES OF A PTHrP ANALOGUE IN REDUCING FRACTURE RISK
[patent_app_type] => utility
[patent_app_number] => 15/694658
[patent_app_country] => US
[patent_app_date] => 2017-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15694658
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/694658 | USES OF A PTHrP ANALOGUE IN REDUCING FRACTURE RISK | Aug 31, 2017 | Abandoned |
Array
(
[id] => 14883507
[patent_doc_number] => 10421780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Peptide for targeting autophagic cells and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/687219
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 9625
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15687219
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/687219 | Peptide for targeting autophagic cells and use thereof | Aug 24, 2017 | Issued |
Array
(
[id] => 16184461
[patent_doc_number] => 10717766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-21
[patent_title] => Antimicrobial peptides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/327047
[patent_app_country] => US
[patent_app_date] => 2017-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 8731
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327047
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/327047 | Antimicrobial peptides and uses thereof | Aug 21, 2017 | Issued |
Array
(
[id] => 12584883
[patent_doc_number] => 20180086790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => BIOACTIVE PEPTIDES HAVING INSECTICIDE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 15/677648
[patent_app_country] => US
[patent_app_date] => 2017-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15677648
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/677648 | Bioactive peptides having insecticide activity | Aug 14, 2017 | Issued |
Array
(
[id] => 13287699
[patent_doc_number] => 10155022
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Fat accumulation inhibitory peptide and pharmaceutical composition for preventing or treating obesity containing the same
[patent_app_type] => utility
[patent_app_number] => 15/666506
[patent_app_country] => US
[patent_app_date] => 2017-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 3577
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15666506
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/666506 | Fat accumulation inhibitory peptide and pharmaceutical composition for preventing or treating obesity containing the same | Jul 31, 2017 | Issued |
Array
(
[id] => 16369083
[patent_doc_number] => 10800824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-13
[patent_title] => AIMP1 protein fragment and skin-protecting composition containing same as active ingredient
[patent_app_type] => utility
[patent_app_number] => 16/320431
[patent_app_country] => US
[patent_app_date] => 2017-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10160
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320431
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320431 | AIMP1 protein fragment and skin-protecting composition containing same as active ingredient | Jul 26, 2017 | Issued |
Array
(
[id] => 16734430
[patent_doc_number] => 10960051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-30
[patent_title] => Methods of treating dry eye syndrome
[patent_app_type] => utility
[patent_app_number] => 16/318571
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 14792
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318571
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318571 | Methods of treating dry eye syndrome | Jul 16, 2017 | Issued |
Array
(
[id] => 12022237
[patent_doc_number] => 20170312337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'METHOD FOR ADMINISTERING OMEGA-CONOPEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 15/651655
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9741
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651655
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/651655 | Method for administering omega-conopeptide | Jul 16, 2017 | Issued |
Array
(
[id] => 12023894
[patent_doc_number] => 20170313993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'VARIANT FORMS OF URATE OXIDASE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/649398
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14847
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15649398
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/649398 | VARIANT FORMS OF URATE OXIDASE AND USE THEREOF | Jul 12, 2017 | Abandoned |
Array
(
[id] => 12254400
[patent_doc_number] => 09926538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Variant forms of urate oxidase and use thereof'
[patent_app_type] => utility
[patent_app_number] => 15/649488
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14921
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15649488
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/649488 | Variant forms of urate oxidase and use thereof | Jul 12, 2017 | Issued |
Array
(
[id] => 13661611
[patent_doc_number] => 10160958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-25
[patent_title] => Variant forms of urate oxidase and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/649478
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13898
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15649478
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/649478 | Variant forms of urate oxidase and use thereof | Jul 12, 2017 | Issued |
Array
(
[id] => 12031093
[patent_doc_number] => 20170321193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'VARIANT FORMS OF URATE OXIDASE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/649462
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14842
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15649462
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/649462 | Variant forms of urate oxidase and use thereof | Jul 12, 2017 | Issued |
Array
(
[id] => 14731437
[patent_doc_number] => 10385108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Peptide analogs of alpha-melanocyte stimulating hormone
[patent_app_type] => utility
[patent_app_number] => 15/645974
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 59
[patent_no_of_words] => 18594
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645974
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645974 | Peptide analogs of alpha-melanocyte stimulating hormone | Jul 9, 2017 | Issued |
Array
(
[id] => 12029555
[patent_doc_number] => 20170319654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'METHOD FOR TREATING MICROBIAL INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/642422
[patent_app_country] => US
[patent_app_date] => 2017-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11125
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15642422
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/642422 | Method for treating microbial infection | Jul 5, 2017 | Issued |
Array
(
[id] => 14746781
[patent_doc_number] => 20190256564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => NEMERTEA-DERIVED BIOACTIVE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/313843
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12766
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313843
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/313843 | NEMERTEA-DERIVED BIOACTIVE COMPOUNDS | Jun 26, 2017 | Abandoned |
Array
(
[id] => 15160845
[patent_doc_number] => 10485895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Self-assembling peptide scaffolds
[patent_app_type] => utility
[patent_app_number] => 15/633549
[patent_app_country] => US
[patent_app_date] => 2017-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6295
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15633549
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/633549 | Self-assembling peptide scaffolds | Jun 25, 2017 | Issued |
Array
(
[id] => 11986615
[patent_doc_number] => 20170290770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'COMPOSITION FOR THE TREATMENT OF BURNS, DIABETIC WOUNDS, OTHER TYPES OF WOUNDS AND SUBSEQUENTLY GREATLY REDUCED SCARRING'
[patent_app_type] => utility
[patent_app_number] => 15/632350
[patent_app_country] => US
[patent_app_date] => 2017-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4969
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15632350
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/632350 | Composition for the treatment of burns, diabetic wounds, other types of wounds and subsequently greatly reduced scarring | Jun 24, 2017 | Issued |
Array
(
[id] => 14501241
[patent_doc_number] => 20190194275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => MENTSH ANALOGS AS THERAPEUTICS FOR DIABETES, OBESITY, AND THEIR ASSOCIATED DISEASES AND COMPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/311599
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311599
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311599 | MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications | Jun 22, 2017 | Issued |
Array
(
[id] => 12030818
[patent_doc_number] => 20170320917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway'
[patent_app_type] => utility
[patent_app_number] => 15/628771
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22668
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15628771
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/628771 | Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway | Jun 20, 2017 | Abandoned |